Impact of the Haemophilus infl uenzae type b vaccination program on HIB meningitis in Brazil

Cadernos de Saude Publica

Volumn 23, Issue 7, 2007, Pages 1689-1695

  Miranzi, Sybelle De Souza Castro ^a   De Moraes, Suzana Alves ^b   De Freitas, Isabel Cristina Martins ^b  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bacterial meningitis; Haemophilus influenzae; Time series studies; Vaccination

Indexed keywords

HAEMOPHILUS VACCINE; VACCINE;

ARTICLE; BACTERIAL MENINGITIS; BRAZIL; FORECASTING; HAEMOPHILUS INFLUENZAE TYPE B; HOSPITAL INFORMATION SYSTEM; HUMAN; IMMUNOLOGY; INCIDENCE; INFANT; MORTALITY; NEWBORN; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; REGRESSION ANALYSIS; STANDARD; SURVIVAL; VACCINATION;

BRAZIL; CHILD, PRESCHOOL; CLINICAL LABORATORY INFORMATION SYSTEMS; FORECASTING; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; INFANT, NEWBORN; MENINGITIS, HAEMOPHILUS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; VACCINATION; VACCINES, CONJUGATE;

EID: 34447136219     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/S0102-311X2007000700021     Document Type: Article

References (32)

1. Freitas HSA, Oliveira RA, Souza BCM. Meningite por Haemophilus: Brasil - 1987/1991. Inf Epidemiol SUS 1993; 2:35-56.
2. Clements DA, Booy R, Dagan R. Comparison of the epidemiology and cost of Haemophilus influenzae type b disease in five western countries. Pediatr Infect Dis J 1993; 12:362-7.
3. Levine OS, Schwartz B, Pierce N, Kane M. Development, evaluation and implementation of Haemophilus influenzae type b vaccines for young children in developing countries: current status and priority actions. Pediatr Infect Dis J 1998; 17:95-113.
4. Ward JI, Zangwill KM. Haemophilus influenzae vaccines. In: Plotkin WA, editor. Vaccines. Philadelphia: Saunders Company; 1999. p. 183-221.
5. Ministério da Saúde. Informe técnico para a implantação da vacina contra o Haemophilus influenzae tipo b. Brasília: Centro Nacional de Epidemiologia, Ministério da Saúde; 1999.
6. Miranzi SSC, Camacho LAB, Valente JG. Haemophilus influenzae tipo b: situação epidemiológica no Estado de Minas Gerais, Brasil, 1993 a 1997. Cad Saúde Pública 2003; 19:1267-75.
7. Box GEP, Jenkins JM, Reinsel GC. Time series analysis: forecasting and control. 3rd Ed. Englewood Cliffs: Prentice- Hall; 1994.
8. World Health Organization. Generic protocol for population-based surveillance of Haemophilus influenzae type b. Atlanta: Centers for Disease Control and Prevention/Geneva: World Health Organization; 1996.
9. Booy R, Hodgson S, Carpenter L, Mayon-White RT, Slack MP, Macfarlane JA, et al. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet 1994; 344:362-6.
10. Decker MD, Edwards K. Haemophilus influenzae type b vaccines: history, choice and comparisons. Pediatr Infect Dis J 1998; 17:113-6.
11. Heath PT. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. Pediatr Infect Dis J 1998; 17:117-22.
12. World Health Organization. Global program for vaccines and immunization (GPV). Wkly Epidemiol Rec 1998; 73:64-71.
13. Lagos R, Horwitz J, Toro J, San Martin O, Abrego P, Bustamante C, et al. Large scale, post licensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatr Infect Dis J 1996; 15:216-22.
14. Mulhollad EK, Helton S, Adegbola RA, Usen S, Oparaugo A, Omosigho C, et al. Randomized trial of Haemophilus influenzae type b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997; 349: 1191-7.
15. Casagrande ST, Vicente EJ, Landgraf IM, Kobata AMM. Antimicrobial resistance patterns of Haemophilus influenzae isolated from patients with meningitis in São Paulo, Brazil. Braz J Med Biol Res 2000; 33:295-300.
16. Zanella RC, Casagrande ST, Bokermann S, Almeida SCG, Brandileone MCC. Characterization of Haemophilus influenzae isolated from invasive disease in Brazil from 1990 to 1999. Microb Drug Resist 2002; 8:67-72.
17. Barton-Forbes MA, Samms-Vaughan M, Irons B. Epidemiology of Haemophilus influenzae invasive disease in Jamaica, 1990-1993. West Indian Med J 2000; 49:200-4.
18. Kamiya H, Uerara S, Kato T, Shiraki K, Togashi T, Morishima T, et al. Childhood bacterial meningitis in Japan. Pediatr Infect Dis J 1998; 17:183-5.
19. Ferraz IQ, Figueiredo AVA, Martins RP, Scala RS, Moreira TCR, Silva TE. Ocorrência de meningites por Neisseria meningitidis, Haemophilus influenzae e Streptococcus pneumoniae no Distrito Federal, no período de 1989 a 1995. Rev Saúde Dist Fed 1996; 7:19-24.
20. Toledo MRF. Haemophilus. In: Trabulsi LR, organizador. Microbiologia. Rio de Janeiro/São Paulo: Editora Atheneu; 1991. p. 133-40.
21. Ministério da Saúde. Norma operacional básica - NOB 001/96. Brasília: Ministério da Saúde; 1996.
22. Simões LLP, Andrade ALSS, Laval CA, Oliveira RM, Silva AS, Martelli CMT, et al. Impacto da vacinação contra Haemophilus influenzae tipo b na redução das meningites, Goiás. Rev Saúde Pública 2004; 38:664-70.
23. Heath PT, Booy R, Griffiths H, Buck E, Azzopardi HI, Slack MPE, et al. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis 2000; 31:973-80.
24. Ruocco G, Curto S, Sávio M, Laurani H, Frocht R. Vacunación contra Haemophilus influenzae tipo b en el Uruguay: experiencia e impacto. Rev Panam Salud Pública 1999; 5:197-9.
25. Fry AM, Lurie, P, Gidley M, Schmink S, Lingappa J, Fischer M, et al. Haemophilus influenzae type b disease among Amish children in Pennsylvania: reasons for persistent disease. Pediatrics 2001; 108: E60.
26. st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000; 13:302-17.
27. Jafari HS, Adams WQ, Robinson KA, Plikaytis BD, Wenger JD. Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. Am J Public Health 1999; 89:364-8.
28. Santosham M. Can Haemophilus influenzae type b disease be eliminated from the United States? J Pediatr 2000; 137:295-8.
29. Zhou F, Bisgard KM, Yusuf HR, Deuson RR, Bath SK, Murphy TV. Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis. Pediatrics 2002; 110:653-61.
30. Slack MPEF, Azzopardi HJ, Hargreaves RM, Ramsay ME. Enhanced surveillance of invasive Haemophilus influenzae disease in England, 1990 to 1996: impact of conjugate vaccines. Pediatr Infect Dis J 1998; 17(9 Suppl):S204-7.
31. Gallo G, Atti MLCD, Cerquetti M, Piovesan C, Tozzi AE, Salmaso S. Impact of a regional vaccination programme in Italy. Vaccine 2002; 20:993-5.
32. Departamento de Informação e Informática do SUS. Informações estatísticas - coberturas. http://pni.datasus. gov.br/inf_estatistica_cobertura.asp (accessed on 09/May/2004).